Global Cell Based Assay Market Is Expected To Reach $40.78 Billion By 2032

Zion Market Research  has published a new report titled “Cell Based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, and Services), by Application (ADME Studies, Predictive Toxicology, Drug Discovery, and Research), and by End-User (CROs, Biopharma Companies, and Research Institutes), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032”. According to the report, the global cell based assay market was approximately USD 18.90 billion in 2023 and is predicted to grow to around USD 40.78 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.92% between 2024 and 2032.

Cell assay is a diagnostic tool that is used to study cellular functions’ mechanisms. Functional cells are used as diagnostic equipment for studying new drugs. Cell-based assays are extensively used in academic institutes, research facilities, government institutes, pharmaceutical and biotechnology companies, and contract research institutes. The increasing incidence of chronic diseases, such as cancer, cardiovascular diseases, arthritis, and diabetes, is the primary growth factor of the cell based assay market globally.

Furthermore, increasing R&D expenditure on drug discovery, the advantage of cell-based assays over other techniques, and growing adoption of throughput screening methods, mainly in toxicological studies, will have a positive impact on the cell based assay market.

However, the high instrument cost and restrictions on reagent usage may act as restraints for the cell based assay market growth globally. Alternatively, the increased use of the novel cell-based assay in cancer research will further contribute to the cell cased assay market development in the future.

Browse the full “Cell Based Assay Market by Product (Reagents, Microplates, Cell Lines, Assay Kits, Instruments, and Services), by Application (ADME Studies, Predictive Toxicology, Drug Discovery, and Research), and by End-User (CROs, Biopharma Companies, and Research Institutes), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024-2032” Report at https://www.zionmarketresearch.com/report/cell-based-assay-market

The cell based assay market is categorized on the basis of application, product, and end-user. On the basis of product, the cell based assay market includes microplates, reagents, services, cell lines, instruments, and assay kits.

Based on application, the market is classified into ADME studies, research, predictive toxicology, and drug discovery. The drug discovery segment is anticipated to witness notable growth in the cell based assay market over the forecast time period.

By end-user, the global cell based assay market includes CROs, biopharma companies, and research institutes. Biopharma companies accounted for the largest share of the cell based assay market in 2018 globally. This can be attributed to the increasing adoption of advanced technologies for disease diagnosis and treatment and rising cancer incidences.

North America dominated the global cell based assay market in 2018, due to the positive government initiatives for investment and funding in cancer research, flourishing pharmaceutical industry, developing economic conditions, and rising business investments. Europe held the second largest market share for the cell based assay market in 2018, due to the rising cancer prevalence, increasing cancer diagnosis procedures, and growing awareness about new advanced technologies.

The Asia Pacific is an emerging region for cell based assay market, due to the increasing cancer cases, growing investments in healthcare services, and rising assay applications.

Cell Based Assay Market: Competitive Analysis

The global cell based assay market is led by players like:

• Becton
• Dickinson and Company
• Bio-Rad Laboratories
• Corning
• Danaher Corporation
• DiscoverX Corporation
• F. Hoffmann-La Roche
• Merck
• Perkin Elmer
• Promega Corporation
• Thermo Fisher Scientific

This report segments the global cell based assay market into:

Global Cell Based Assay Market: By Product

• Reagents
• Microplates
• Cell Lines
• Assay Kits
• Instruments
• Services

Global Cell Based Assay Market: By Application

• ADME Studies
• Predictive Toxicology
• Drug Discovery
• Research

Global Cell Based Assay Market: By End-User

• CROs
• Biopharma Companies
• Research Institutes

Global Cell Based Assay Market: By Region

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com